Dr. Cameron Durrant, M.D., J.D., M.B.A.

Dr. Durrant is an entrepreneur, board member, C-level executive, former big pharma executive, and an MD by original training. He is Chairman and CEO of Humanigen, a Nasdaq-listed public company developing biologics for a range of serious and life-threatening conditions. His specialty is both startups and turnarounds, including brands and business units as well as...

Dr. Esteban Pombo Villar, P.hD

Dr. Pombo-Villar is currently the CTO of TargImmune Therapeutics AG in Switzerland. He held the post of CEO position from its seed stage in 2017 until August 2021. Under his leadership, the company developed the innovative targeted immunooncology platform and its lead project into IND-enabling studies, established the operations in Basel, and raised over CHF...

Dr. Duane Mitchell, M.D., P.hD

Dr. Mitchell is Co-Founder, President, and Chairman of iOncologi, Inc., a biotechnology ‘spinout’ company from the University of Florida (UF) specializing in immuno-oncology. Dr. Mitchell is the Phyllis Kottler Friedman Professor in the Lillian S. Wells Department of Neurosurgery at UF. He serves as Director of the UF Clinical Translational Science Institute (CTSI) and Co-Director...

Fumihiko Urano, MD, P.hD

Fumihiko “Fumi” Urano, MD, PhD, FACMG, is a Physician and Medical Researcher specializing in Wolfram syndrome, characterized by juvenile-onset diabetes, vision loss, and brain system disruption. Dr. Urano is a Professor of Medicine and Pathology & Immunology, an attending physician, and currently holds Samuel E. Schechter Endowed Professorship in Medicine at Washington University School of...

Dr. Peter Kash, Ed.D., MBA

Dr. Peter Kash is a co-founder and Vice-Chairman of TargImmune Therapeutics (Switzerland). Peter is a Co-founder in SKV, a biotech private equity fund. He was formerly a co-founder and partner and Chairman of Two River Group and President of Riverbank Capital Securities specializing in creating and financing several biotech companies including Kite Pharma, Edgemont Pharmaceuticals,...

Dr. Colby Kash, D.C., M.S.

Dr. Kash graduated Cum Laude from the University of Florida’s College of Health and Human Performance with a Bachelor’s in Applied Physiology and Kinesiology. He later went on to receive his Doctor of Chiropractic and Master of Science degree in Applied Clinical Nutrition from Northeast College of Health Sciences. He practiced Functional Medicine in the...

Matthew Bronfman

Mr. Matthew Bronfman is the Chairman and CEO of BHB Holdings, a private investment firm with numerous interests. He served as Chairman of Bronfman Rothschild, a Washington, D.C. based Registered Investment Advisor. In addition, Mr. Bronfman controls the IKEA franchise in Israel and has numerous real estate holdings there and in the U.S. He also...

Dr. Josh Sharan, DO

Dr. Josh Sharan graduated with multiple honors recognitions from Nova Southeastern University’s College of Osteopathic Medicine. He has performed extensive research in the field of regenerative medicine, describing in literature multiple first in human responses to mesenchymal stem cell therapy for various orthopedic and autoimmune conditions. Much of his work has been presented at the...

Dr. Linda Friedland, M.D.

Dr. Friedland is a physician with over 25 years of experience in clinical medicine and an international advisor to many Fortune and Forbes global companies. She consults with healthcare, biotech, corporate, and financial institutions. Among her roles, Dr. Friedland is the head of Business Development at Firebrick Pharma (Australia), senior consultant to TargImmune Therapeutics (Basel,...

Dr. Spencer Martinez Rice, DO

Dr. Rice graduated with honors from Nova Southeastern University’s College of Osteopathic Medicine. As Vice President, with a background in both business and healthcare, Dr. Rice is responsible for identifying and pursuing new business opportunities. He assists all C-suite personnel and spends much of his focus in the preclinical and clinical development of the company’s...

Scroll to top